BIOPLUS ACQUISITION CORP - *W EXP 12/02/202 (BIOSW) Institutional Ownership

CUSIP: G11217125

13F Institutional Holders and Ownership History from Q1 2022 to Q4 2023

Type / Class
Equity / *W EXP 12/02/202
Symbol
BIOSW
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP G11217125?
CUSIP G11217125 identifies BIOSW - BIOPLUS ACQUISITION CORP - *W EXP 12/02/202 in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Institutional Holders of BIOPLUS ACQUISITION CORP - *W EXP 12/02/202 (BIOSW) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2023 Q4 0 $0 -$429,338 0
2023 Q3 7,658,459 $429,338 -$4,118 $0.06 41
2023 Q2 9,397,302 $1,334,588 +$62,736 $0.15 45
2023 Q1 9,097,811 $804,195 +$15,198 $0.09 42
2022 Q4 4,387,939 $205,515 -$14,944 $0.05 18
2022 Q3 4,096,356 $539,000 +$57,291 $0.14 20
2022 Q2 6,089,638 $838,000 +$60,913 $0.14 36
2022 Q1 7,732,809 $1,751,000 +$1,751,000 $0.23 41